42C.SI
Price:
$0.116
Market Cap:
$100.11M
iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia. The company operates through Specialty Pharmaceutical and Nutraceutical segments. It offers Wafesil and Silcap for the treatment of male erectile dysfunction; and Xativa, a sublingual cannabidiol wafer, as well as Hypera, a sublingual tetrahydrocannabinol wafer for chronic pain, anxiety, and insomnia. The company is also developing Wafermine, a racemic ketamine sublingual wafer, which has completed phase-2 clinical trial for the treatmen...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-07-22
Stock Exchange
SES
Ticker
42C.SI
According to iX Biopharma Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.47. This represents a change of -46.76% compared to the average of 0.88 of the last 4 quarters.
The mean historical Current Ratio of iX Biopharma Ltd. over the last ten years is 4.04. The current 0.47 Current Ratio has changed 1.06% with respect to the historical average. Over the past ten years (40 quarters), 42C.SI's Current Ratio was at its highest in in the December 2016 quarter at 12.62. The Current Ratio was at its lowest in in the June 2025 quarter at 0.47.
Average
4.04
Median
2.51
Minimum
0.47
Maximum
10.74
Discovering the peaks and valleys of iX Biopharma Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 303.21%
Maximum Annual Current Ratio = 10.74
Minimum Annual Increase = -66.23%
Minimum Annual Current Ratio = 0.47
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.47 | -47.47% |
| 2024 | 0.89 | -41.69% |
| 2023 | 1.53 | -28.64% |
| 2022 | 2.14 | -15.91% |
| 2021 | 2.55 | 3.25% |
| 2020 | 2.47 | -66.23% |
| 2019 | 7.31 | 116.30% |
| 2018 | 3.38 | -62.14% |
| 2017 | 8.93 | -16.89% |
| 2016 | 10.74 | 303.21% |
The current Current Ratio of iX Biopharma Ltd. (42C.SI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.96
5-year avg
1.52
10-year avg
4.04
iX Biopharma Ltd.’s Current Ratio is less than UG Healthcare Corporation Limited (2.70), less than HC Surgical Specialists Limited (1.72), less than Cordlife Group Limited (3.13), greater than Singapore Institute of Advanced Medicine Holdings Ltd. (0.31), less than Vicplas International Ltd (1.46), less than Embracing Future Holdings Limited (0.58), less than Medinex Limited (2.59), less than Niks Professional Ltd (5.31), less than Medi Lifestyle Limited (0.52), less than Clearbridge Health Limited (1.73),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.70 | $60.51M | |
| 1.72 | $52.15M | |
| 3.13 | $33.58M | |
| 0.31 | $68.07M | |
| 1.46 | $49.57M | |
| 0.58 | $53.74M | |
| 2.59 | $32.51M | |
| 5.31 | $29.25M | |
| 0.52 | $1.31M | |
| 1.73 | $4.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iX Biopharma Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like iX Biopharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is iX Biopharma Ltd.'s Current Ratio?
How is the Current Ratio calculated for iX Biopharma Ltd. (42C.SI)?
What is the highest Current Ratio for iX Biopharma Ltd. (42C.SI)?
What is the 3-year average Current Ratio for iX Biopharma Ltd. (42C.SI)?
What is the 5-year average Current Ratio for iX Biopharma Ltd. (42C.SI)?
How does the current Current Ratio for iX Biopharma Ltd. (42C.SI) compare to its historical average?